- Home
- APWC vs RLYB Comparison
APWC vs RLYB Comparison
Compare APWC & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APWC
- RLYB
- Stock Information
- Founded
- APWC 1996
- RLYB 2018
- Country
- APWC Taiwan
- RLYB United States
- Employees
- APWC N/A
- RLYB N/A
- Industry
- APWC Telecommunications Equipment
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- APWC Industrials
- RLYB Health Care
- Exchange
- APWC Nasdaq
- RLYB Nasdaq
- Market Cap
- APWC 38.9M
- RLYB 45.2M
- IPO Year
- APWC 1997
- RLYB 2021
- Fundamental
- Price
- APWC $1.58
- RLYB $1.00
- Analyst Decision
- APWC
- RLYB Buy
- Analyst Count
- APWC 0
- RLYB 6
- Target Price
- APWC N/A
- RLYB $8.10
- AVG Volume (30 Days)
- APWC 13.3K
- RLYB 93.5K
- Earning Date
- APWC 08-26-2024
- RLYB 11-07-2024
- Dividend Yield
- APWC N/A
- RLYB N/A
- EPS Growth
- APWC N/A
- RLYB N/A
- EPS
- APWC 0.18
- RLYB N/A
- Revenue
- APWC $468,125,000.00
- RLYB $598,000.00
- Revenue This Year
- APWC N/A
- RLYB N/A
- Revenue Next Year
- APWC N/A
- RLYB N/A
- P/E Ratio
- APWC $8.87
- RLYB N/A
- Revenue Growth
- APWC 12.16
- RLYB N/A
- 52 Week Low
- APWC $1.20
- RLYB $0.95
- 52 Week High
- APWC $2.02
- RLYB $3.46
- Technical
- Relative Strength Index (RSI)
- APWC 36.90
- RLYB 43.40
- Support Level
- APWC $1.52
- RLYB $1.00
- Resistance Level
- APWC $1.70
- RLYB $1.24
- Average True Range (ATR)
- APWC 0.08
- RLYB 0.08
- MACD
- APWC -0.02
- RLYB -0.01
- Stochastic Oscillator
- APWC 6.98
- RLYB 7.59
About APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in owning operating companies engaged in the power cable, telecommunication cable, enameled wire, and electronic cable industry. It also provides project engineering services to customers. Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.